Abstract
Background
Diffuse large B-cell lymphoma (DLBCL) is the most common lymphoid malignancy in adults. Current studies have implicated that long non-coding RNAs (lncRNAs) regulate the development of DLBCL; nevertheless, the control method is dim. Here, we reconnoitered the characters of lncRNA small nucleolar RNA host gene 12 (lncRNA SNHG12) in DLBCL.
Objective
The pathological morphology of tumor tissues and normal tissues was perceived by hematoxylin–eosin (HE) staining. The levels of SNHG12, microRNA-494-3p (miR-494-3p), and chromobox 3 (CBX3) were detected by quantitative real-time PCR and western blot. Whereafter, MTT assay and EdU assay were enforced to validate cell proliferation. Flow cytometry assay was implemented to assess the cell cycle and cell apoptosis, respectively. Additionally, the interface between miR-494-3p with SNHG12 or CBX3 was identified by dual-luciferase reporter assay.
Results
SNHG12 and CBX3 were enhanced, but miR-494-3p was diminished in DLBCL. Knockdown of SNHG12 repressed cell proliferation and cell cycle, although heightened cell apoptosis in DLBCL cells. SNHG12 sponged miR-494-3p to adjust the CBX3. Additionally, miR-494-3p restrained DLBCL cells development by targeting CBX3.
Conclusion
SNHG12 contributed to DLBCL development by regulating miR-494-3p/CBX3. The outcomes demonstrated that SNHG12 provided a potential train of thought for DLBCL theory of targeted therapy.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Availability of data and materials
All data generated or analyzed during this study are included in this article.
References
Akhade VS, Pal D, Kanduri C (2017) Long Noncoding RNA: genome organization and mechanism of action. Adv Exp Med Biol 1008:47–74
Ambros V (2004) The functions of animal microRNAs. Nature 431(7006):350–355
Armitage JO (2012) My treatment approach to patients with diffuse large B-cell lymphoma. Mayo Clin Proc 87(2):161–171
Canzio D, Larson A, Narlikar GJ (2014) Mechanisms of functional promiscuity by HP1 proteins. Trends Cell Biol 24(6):377–386
Chen LY et al (2018) CBX3 promotes proliferation and regulates glycolysis via suppressing FBP1 in pancreatic cancer. Biochem Biophys Res Commun 500(3):691–697
Chen LY, Zhang XM, Han BQ, Dai HB (2020a) Long noncoding RNA SNHG12 indicates the prognosis and accelerates tumorigenesis of diffuse large B-Cell lymphoma through sponging microR-195. Onco Targets Ther 13:5563–5574
Chen B, Ji F, Wen X, Jin Z (2020b) Circular RNA circ_ASAP2 promotes cell viability, migration, and invasion of gastric cancer cells by regulating the miR-770-5p/CDK6 axis. Int J Clin Exp Pathol 13(11):2806–2819
Fan Y, Li H, Liang X, Xiang Z (2017) CBX3 promotes colon cancer cell proliferation by CDK6 kinase-independent function during cell cycle. Oncotarget 8(12):19934–19946
Fisher RI et al (1993) Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin’s lymphoma. N Engl J Med 328(14):1002–1006
Garzon R, Marcucci G, Croce CM (2010) Targeting microRNAs in cancer: rationale, strategies and challenges. Nat Rev Drug Discov 9(10):775–789
Hou W, Zhang Y (2021) Circ_0025033 promotes the progression of ovarian cancer by activating the expression of LSM4 via targeting miR-184. Pathol Res Pract 217:153275
Lin H et al (2018) MiR-494-3p promotes PI3K/AKT pathway hyperactivation and human hepatocellular carcinoma progression by targeting PTEN. Sci Rep 8(1):10461
Lin H, Lian J, Xia L, Guan G, You J (2020) CBX3 promotes gastric cancer progression and affects factors related to immunotherapeutic responses. Cancer Manag Res 12:10113–10125
Liu Y et al (2020a) Long non-coding RNA SNHG12 promotes tumour progression and sunitinib resistance by upregulating CDCA3 in renal cell carcinoma. Cell Death Dis 11(7):515
Liu S, Wu M, Peng M (2020b) Circ_0000260 regulates the development and deterioration of gastric adenocarcinoma with cisplatin resistance by upregulating MMP11 via targeting MiR-129-5p. Cancer Manag Res 12:10505–10519
Lu C et al (2020) DNA-methylation-mediated activating of lncRNA SNHG12 promotes temozolomide resistance in glioblastoma. Mol Cancer 19(1):28
Ma C et al (2019) CBX3 predicts an unfavorable prognosis and promotes tumorigenesis in osteosarcoma. Mol Med Rep 19(5):4205–4212
Qian CS, Li LJ, Huang HW, Yang HF, Wu DP (2020) MYC-regulated lncRNA NEAT1 promotes B cell proliferation and lymphomagenesis via the miR-34b-5p-GLI1 pathway in diffuse large B-cell lymphoma. Cancer Cell Int 20:87
Qiu G et al (2020) Long noncoding RNA WT1-AS inhibit cell malignancy via miR-494–3p in glioma. Technol Cancer Res Treat 19:1533033820919759
Roschewski M, Staudt LM, Wilson WH (2014) Diffuse large B-cell lymphoma-treatment approaches in the molecular era. Nat Rev Clin Oncol 11(1):12–23
Siegel R, Naishadham D, Jemal A (2013) Cancer statistics, 2013. CA Cancer J Clin 63(1):11–30
Song Y, Gao F, Peng Y, Yang X (2020) Long non-coding RNA DBH-AS1 promotes cancer progression in diffuse large B-cell lymphoma by targeting FN1 via RNA-binding protein BUD13. Cell Biol Int 44(6):1331–1340
Wang Y et al (2017) Discovery and validation of the tumor-suppressive function of long non-coding RNA PANDA in human diffuse large B-cell lymphoma through the inactivation of MAPK/ERK signaling pathway. Oncotarget 8(42):72182–72196
Wang C, Shao S, Deng L, Wang S, Zhang Y (2020a) LncRNA SNHG12 regulates the radiosensitivity of cervical cancer through the miR-148a/CDK1 pathway. Cancer Cell Int 20(1):554
Wang Z, Jiang Z, Zhou J, Liu Z (2020b) circRNA RNF111 regulates the growth, migration and invasion of gastric cancer cells by binding to miR27b3p. Int J Mol Med 46(5):1873–1885
Xu Y et al (2020) MiRNA-340-5p mediates the functional and infiltrative promotion of tumor-infiltrating CD8(+) T lymphocytes in human diffuse large B cell lymphoma. J Exp Clin Cancer Res 39(1):238
Zhu L, Wang X, Wang T, Zhu W, Zhou X (2019) miR4943p promotes the progression of endometrial cancer by regulating the PTEN/PI3K/AKT pathway. Mol Med Rep 19(1):581–588
Acknowledgements
None.
Funding
No funding.
Author information
Authors and Affiliations
Contributions
Conceptualization: CS and WZ. Data curation: CS and WZ. Formal analysis: CS, WZ, and QH. Investigation: QH. Methodology: CS, WZ, QH, and BZ. Recourse: BZ and CZ. Software: BZ and CZ. Writing—original draft: CS. Writing—review and editing: CZ.
Corresponding author
Ethics declarations
Conflict of interest
Cheng Si declares that he has no conflict of interest. Wanyong Zhang declares that he has no conflict of interest. Qi Han declares that he has no conflict of interest. Bisheng Zhu declares that he has no conflict of interest. Chengzhi Zhan declares that he has no conflict of interest.
Ethical approval
The studies involving human participants were reviewed and supported by Chibi General Hospital.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Si, C., Zhang, W., Han, Q. et al. LncRNA SNHG12/miR-494-3p/CBX3 axis in diffuse large B-cell lymphoma. Mol. Cell. Toxicol. 19, 53–62 (2023). https://doi.org/10.1007/s13273-022-00237-x
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13273-022-00237-x